AI Science Tracker
EN

Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis.

Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai; Rutgers University · 23 Jun 2021 · medicine

Discovery

Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis.

Source check: Source checked. Not independent scientific confirmation.

Finding: In 53,454 participants, the paper reported no statistically significant overall lung-cancer or overall-mortality benefit, while describing exploratory subgroup patterns. The subgroup patterns are exploratory retrospective causal-inference estimates, not confirmed treatment effects or prospective screening benefit.

Technology: AFT-BART estimated censored survival counterfactuals from National Lung Screening Trial data, and a tree summarized heterogeneous subgroup treatment-effect estimates.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
AFT-BART estimated censored survival counterfactuals from National Lung Screening Trial data, and a tree summarized heterogeneous subgroup treatment-effect estimates.
Test and result
In 53,454 participants, the paper reported no statistically significant overall lung-cancer or overall-mortality benefit, while describing exploratory subgroup patterns.
Limitation / still unknown
The subgroup patterns are exploratory retrospective causal-inference estimates, not confirmed treatment effects or prospective screening benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8463451/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.